ERBB2 and gastric cancer: The overexpression of HER2 in gastric cancer is found mainly in the gastroesophageal junction and proximal parts compared to the distal parts of the stomach, in a heterogeneous pattern, and this overexpression and amplification is closely related to increased malignancy and poor prognosis.